APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single Nucleotide Polymorphism (SNP) Genotyping

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Selected research

Market Analysis & Forecast

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast 2026-2032

21 December 2025218 pages

Choose your research edition.

Industry ResearchSingle Nucleotide Polymorphism (SNP) Genotyping Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Single Nucleotide Polymorphism (SNP) Genotyping Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%.

North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent.

Read the full market overview

In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.

Report Includes

This report presents an overview of global market for Single Nucleotide Polymorphism (SNP) Genotyping, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Single Nucleotide Polymorphism (SNP) Genotyping, also provides the revenue of main regions and countries. Of the upcoming market potential for Single Nucleotide Polymorphism (SNP) Genotyping, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Single Nucleotide Polymorphism (SNP) Genotyping revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Single Nucleotide Polymorphism (SNP) Genotyping market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Single Nucleotide Polymorphism (SNP) Genotyping revenue, projected growth trends, production technology, application and end-user industry.

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Company

Illumina

Affymetrix

Applied Biosystems

Agilent Technologies

Beckman Coulter

Roche

Qiagen

Luminex Corporation

Enzo Life Sciences

Bio-rad

Sequenom

Ocimum Biosolutions

GE Healthcare

GenScript

Douglas Scientific

BGI

Beijing Sunbiotech

HuaGene Biotech

Generay Biotech

Benegene

Shanghai Biochip

GENESKY

HD Biosciences

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Type

Transversion

Transition

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Application

Diagnostics

Animal

Plant

Research

Others

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Nucleotide Polymorphism (SNP) Genotyping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single Nucleotide Polymorphism (SNP) Genotyping and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Nucleotide Polymorphism (SNP) Genotyping.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Single Nucleotide Polymorphism (SNP) Genotyping in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Single Nucleotide Polymorphism (SNP) Genotyping company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Single Nucleotide Polymorphism (SNP) Genotyping revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Transversion Major Player Table 3. Transition Major Player Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diagnostics Major Player Table 6. Animal Major Player Table 7. Plant Major Player Table 8. Research Major Player Table 9. Others Major Player Table 10. Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends Table 11. Single Nucleotide Polymorphism (SNP) Genotyping Industry Drivers Table 12. Single Nucleotide Polymorphism (SNP) Genotyping Industry Opportunities and Challenges Table 13. Single Nucleotide Polymorphism (SNP) Genotyping Industry Restraints Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2021-2026) Table 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2027-2032) Table 19. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2021-2026) Table 21. Global Single Nucleotide Polymorphism (SNP) Genotyping Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Single Nucleotide Polymorphism (SNP) Genotyping Key Players Headquarters & Area Served Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Players, Product Type & Application Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2021-2026) Table 31. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2027-2032) Table 32. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2021-2026) Table 36. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2027-2032) Table 37. Illumina Company Information Table 38. Illumina Business Overview Table 39. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 41. Illumina Recent Development Table 42. Affymetrix Company Information Table 43. Affymetrix Business Overview Table 44. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 46. Affymetrix Recent Development Table 47. Applied Biosystems Company Information Table 48. Applied Biosystems Business Overview Table 49. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 51. Applied Biosystems Recent Development Table 52. Agilent Technologies Company Information Table 53. Agilent Technologies Business Overview Table 54. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 56. Agilent Technologies Recent Development Table 57. Beckman Coulter Company Information Table 58. Beckman Coulter Business Overview Table 59. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 61. Beckman Coulter Recent Development Table 62. Roche Company Information Table 63. Roche Business Overview Table 64. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 66. Roche Recent Development Table 67. Qiagen Company Information Table 68. Qiagen Business Overview Table 69. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 71. Qiagen Recent Development Table 72. Luminex Corporation Company Information Table 73. Luminex Corporation Business Overview Table 74. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 76. Luminex Corporation Recent Development Table 77. Enzo Life Sciences Company Information Table 78. Enzo Life Sciences Business Overview Table 79. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 81. Enzo Life Sciences Recent Development Table 82. Bio-rad Company Information Table 83. Bio-rad Business Overview Table 84. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 86. Bio-rad Recent Development Table 87. Sequenom Company Information Table 88. Sequenom Business Overview Table 89. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 91. Sequenom Recent Development Table 92. Ocimum Biosolutions Company Information Table 93. Ocimum Biosolutions Business Overview Table 94. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 96. Ocimum Biosolutions Recent Development Table 97. GE Healthcare Company Information Table 98. GE Healthcare Business Overview Table 99. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 101. GE Healthcare Recent Development Table 102. GenScript Company Information Table 103. GenScript Business Overview Table 104. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 106. GenScript Recent Development Table 107. Douglas Scientific Company Information Table 108. Douglas Scientific Business Overview Table 109. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 111. Douglas Scientific Recent Development Table 112. BGI Company Information Table 113. BGI Business Overview Table 114. BGI Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 116. BGI Recent Development Table 117. Beijing Sunbiotech Company Information Table 118. Beijing Sunbiotech Business Overview Table 119. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 121. Beijing Sunbiotech Recent Development Table 122. HuaGene Biotech Company Information Table 123. HuaGene Biotech Business Overview Table 124. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 126. HuaGene Biotech Recent Development Table 127. Generay Biotech Company Information Table 128. Generay Biotech Business Overview Table 129. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 130. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 131. Generay Biotech Recent Development Table 132. Benegene Company Information Table 133. Benegene Business Overview Table 134. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 135. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 136. Benegene Recent Development Table 137. Shanghai Biochip Company Information Table 138. Shanghai Biochip Business Overview Table 139. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 140. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 141. Shanghai Biochip Recent Development Table 142. GENESKY Company Information Table 143. GENESKY Business Overview Table 144. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 145. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 146. GENESKY Recent Development Table 147. HD Biosciences Company Information Table 148. HD Biosciences Business Overview Table 149. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 150. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 151. HD Biosciences Recent Development Table 152. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026) & (US$ Million) Table 153. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032) & (US$ Million) Table 154. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026) & (US$ Million) Table 155. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032) & (US$ Million) Table 156. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021-2026) & (US$ Million) Table 158. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (US$ Million) & (2027-2032) Table 159. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026) & (US$ Million) Table 160. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032) & (US$ Million) Table 161. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021-2026) & (US$ Million) Table 165. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (US$ Million) & (2027-2032) Table 166. China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026) & (US$ Million) Table 167. China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032) & (US$ Million) Table 168. China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026) & (US$ Million) Table 169. China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026) & (US$ Million) Table 171. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032) & (US$ Million) Table 172. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (US$ Million) & (2021-2026) Table 176. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (US$ Million) & (2027-2032) Table 177. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021-2026) & (US$ Million) Table 183. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (US$ Million) & (2027-2032) Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Single Nucleotide Polymorphism (SNP) Genotyping Image Figure 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share 2021 VS 2025 VS 2032 Figure 4. Transversion Image Figure 5. Transition Image Figure 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diagnostics Image Figure 9. Animal Image Figure 10. Plant Image Figure 11. Research Image Figure 12. Others Image Figure 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million) & (2021-2032) Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2021-2032) Figure 21. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2021-2032) Figure 24. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032) Figure 26. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032) Figure 27. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Country (2021-2032) Figure 28. United States Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032) Figure 33. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032) Figure 34. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Country (2021-2032) Figure 35. Germany Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032) Figure 45. China Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032) Figure 46. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032) Figure 48. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032) Figure 49. Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Region (2021-2032) Figure 50. Japan Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032) Figure 58. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032) Figure 59. SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Country (2021-2032) Figure 60. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Single Nucleotide Polymorphism (SNP) Genotyping Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Transversion
  • Transition
Applications
  • Diagnostics
  • Animal
  • Plant
  • Research
  • Others
Companies covered
  • Illumina
  • Affymetrix
  • Applied Biosystems
  • Agilent Technologies
  • Beckman Coulter
  • Roche
  • Qiagen
  • Luminex Corporation
  • Enzo Life Sciences
  • Bio-rad
  • Sequenom
  • Ocimum Biosolutions
  • GE Healthcare
  • GenScript
  • Douglas Scientific
  • BGI
  • Beijing Sunbiotech
  • HuaGene Biotech
  • Generay Biotech
  • Benegene
  • Shanghai Biochip
  • GENESKY
  • HD Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Single Nucleotide Polymorphism (SNP) Genotyping Market by Type
  3. 1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Transversion
  5. 1.2.3 Transition
  6. 1.3 Single Nucleotide Polymorphism (SNP) Genotyping Market by Application
  7. 1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diagnostics
  9. 1.3.3 Animal
  10. 1.3.4 Plant
  11. 1.3.5 Research
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Single Nucleotide Polymorphism (SNP) Genotyping Market Dynamics
  1. 2.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
  2. 2.2 Single Nucleotide Polymorphism (SNP) Genotyping Industry Drivers
  3. 2.3 Single Nucleotide Polymorphism (SNP) Genotyping Industry Opportunities and Challenges
  4. 2.4 Single Nucleotide Polymorphism (SNP) Genotyping Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2021-2032)
  2. 3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Region
  3. 3.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2021-2026)
  5. 3.2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players
  2. 4.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2021-2026)
  3. 4.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Key Players Headquarters & Area Served
  7. 4.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Players, Product Type & Application
  8. 4.5 Global Single Nucleotide Polymorphism (SNP) Genotyping Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market CR5 and HHI
  11. 4.6.3 2025 Single Nucleotide Polymorphism (SNP) Genotyping Tier 1, Tier 2, and Tier 3
5 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
  1. 5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2032)
  3. 5.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2021-2032)
6 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
  1. 6.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2032)
  3. 6.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Illumina
  2. 7.1.1 Illumina Company Information
  3. 7.1.2 Illumina Business Overview
  4. 7.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  6. 7.1.5 Illumina Recent Developments
  7. 7.2 Affymetrix
  8. 7.2.1 Affymetrix Company Information
  9. 7.2.2 Affymetrix Business Overview
  10. 7.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  12. 7.2.5 Affymetrix Recent Developments
  13. 7.3 Applied Biosystems
  14. 7.3.1 Applied Biosystems Company Information
  15. 7.3.2 Applied Biosystems Business Overview
  16. 7.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  18. 7.3.5 Applied Biosystems Recent Developments
  19. 7.4 Agilent Technologies
  20. 7.4.1 Agilent Technologies Company Information
  21. 7.4.2 Agilent Technologies Business Overview
  22. 7.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  24. 7.4.5 Agilent Technologies Recent Developments
  25. 7.5 Beckman Coulter
  26. 7.5.1 Beckman Coulter Company Information
  27. 7.5.2 Beckman Coulter Business Overview
  28. 7.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  30. 7.5.5 Beckman Coulter Recent Developments
  31. 7.6 Roche
  32. 7.6.1 Roche Company Information
  33. 7.6.2 Roche Business Overview
  34. 7.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  36. 7.6.5 Roche Recent Developments
  37. 7.7 Qiagen
  38. 7.7.1 Qiagen Company Information
  39. 7.7.2 Qiagen Business Overview
  40. 7.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  42. 7.7.5 Qiagen Recent Developments
  43. 7.8 Luminex Corporation
  44. 7.8.1 Luminex Corporation Company Information
  45. 7.8.2 Luminex Corporation Business Overview
  46. 7.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  48. 7.8.5 Luminex Corporation Recent Developments
  49. 7.9 Enzo Life Sciences
  50. 7.9.1 Enzo Life Sciences Company Information
  51. 7.9.2 Enzo Life Sciences Business Overview
  52. 7.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  54. 7.9.5 Enzo Life Sciences Recent Developments
  55. 7.10 Bio-rad
  56. 7.10.1 Bio-rad Company Information
  57. 7.10.2 Bio-rad Business Overview
  58. 7.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  60. 7.10.5 Bio-rad Recent Developments
  61. 7.11 Sequenom
  62. 7.11.1 Sequenom Company Information
  63. 7.11.2 Sequenom Business Overview
  64. 7.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  66. 7.11.5 Sequenom Recent Developments
  67. 7.12 Ocimum Biosolutions
  68. 7.12.1 Ocimum Biosolutions Company Information
  69. 7.12.2 Ocimum Biosolutions Business Overview
  70. 7.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  72. 7.12.5 Ocimum Biosolutions Recent Developments
  73. 7.13 GE Healthcare
  74. 7.13.1 GE Healthcare Company Information
  75. 7.13.2 GE Healthcare Business Overview
  76. 7.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  78. 7.13.5 GE Healthcare Recent Developments
  79. 7.14 GenScript
  80. 7.14.1 GenScript Company Information
  81. 7.14.2 GenScript Business Overview
  82. 7.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  83. 7.14.4 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  84. 7.14.5 GenScript Recent Developments
  85. 7.15 Douglas Scientific
  86. 7.15.1 Douglas Scientific Company Information
  87. 7.15.2 Douglas Scientific Business Overview
  88. 7.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  90. 7.15.5 Douglas Scientific Recent Developments
  91. 7.16 BGI
  92. 7.16.1 BGI Company Information
  93. 7.16.2 BGI Business Overview
  94. 7.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  96. 7.16.5 BGI Recent Developments
  97. 7.17 Beijing Sunbiotech
  98. 7.17.1 Beijing Sunbiotech Company Information
  99. 7.17.2 Beijing Sunbiotech Business Overview
  100. 7.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  102. 7.17.5 Beijing Sunbiotech Recent Developments
  103. 7.18 HuaGene Biotech
  104. 7.18.1 HuaGene Biotech Company Information
  105. 7.18.2 HuaGene Biotech Business Overview
  106. 7.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  107. 7.18.4 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  108. 7.18.5 HuaGene Biotech Recent Developments
  109. 7.19 Generay Biotech
  110. 7.19.1 Generay Biotech Company Information
  111. 7.19.2 Generay Biotech Business Overview
  112. 7.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  114. 7.19.5 Generay Biotech Recent Developments
  115. 7.20 Benegene
  116. 7.20.1 Benegene Company Information
  117. 7.20.2 Benegene Business Overview
  118. 7.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  120. 7.20.5 Benegene Recent Developments
  121. 7.21 Shanghai Biochip
  122. 7.21.1 Shanghai Biochip Company Information
  123. 7.21.2 Shanghai Biochip Business Overview
  124. 7.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  126. 7.21.5 Shanghai Biochip Recent Developments
  127. 7.22 GENESKY
  128. 7.22.1 GENESKY Company Information
  129. 7.22.2 GENESKY Business Overview
  130. 7.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  131. 7.22.4 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  132. 7.22.5 GENESKY Recent Developments
  133. 7.23 HD Biosciences
  134. 7.23.1 HD Biosciences Company Information
  135. 7.23.2 HD Biosciences Business Overview
  136. 7.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2021-2026)
  137. 7.23.4 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  138. 7.23.5 HD Biosciences Recent Developments
8 North America
  1. 8.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2021-2032)
  2. 8.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2032)
  3. 8.2.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026)
  4. 8.2.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032)
  5. 8.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032)
  6. 8.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2032)
  7. 8.4.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026)
  8. 8.4.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032)
  9. 8.5 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032)
  10. 8.6 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country
  11. 8.6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021-2026)
  13. 8.6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2021-2032)
  2. 9.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2032)
  3. 9.2.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026)
  4. 9.2.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032)
  5. 9.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032)
  6. 9.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2032)
  7. 9.4.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026)
  8. 9.4.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032)
  9. 9.5 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032)
  10. 9.6 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country
  11. 9.6.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021-2026)
  13. 9.6.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2021-2032)
  2. 10.2 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2032)
  3. 10.2.1 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026)
  4. 10.2.2 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032)
  5. 10.3 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032)
  6. 10.4 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2032)
  7. 10.4.1 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026)
  8. 10.4.2 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032)
  9. 10.5 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2021-2032)
  2. 11.2 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2032)
  3. 11.2.1 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026)
  4. 11.2.2 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032)
  5. 11.3 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032)
  6. 11.4 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2032)
  7. 11.4.1 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026)
  8. 11.4.2 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032)
  9. 11.5 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032)
  10. 11.6 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country
  11. 11.6.1 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021-2026)
  13. 11.6.3 Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2021-2032)
  2. 12.2 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2027-2032)
  5. 12.3 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2027-2032)
  9. 12.5 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country
  11. 12.6.1 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst